Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-01-31 @ 5:20 AM
Study NCT ID:
NCT01133158
Status:
COMPLETED
Last Update Posted:
2018-11-01
First Post:
2010-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial
Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization: